12/3
09:03 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
10/16
10:02 am
ocul
Rating for OCUL
Medium
Report
Rating for OCUL
10/16
10:02 am
ocul
Rating for OCUL
Medium
Report
Rating for OCUL
10/16
08:44 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Medium
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/16
08:44 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Medium
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/16
08:31 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Medium
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.